Skip to Content

Students

Current Students

Ai, Midan
Chen, Lin
Chen, Lu
Cheng, Tiewei (Leo)
Dhupkar, Pooja
Ihle, Nathan
Lu, Haiquan
Martinez-Rivera, Michelle
Morrow, John
Patel, Viralkumar
Randhawa, Shubhchintan
Riaz Ahmed, Kausar Begam
Rivera-Del Valle, Nilsa
Shah, Maitri
Vu, Thuy
White, Matt
Yang, Qingshan (Carly)
Zhang, Xue

Midan Ai

Midan AiEmail: midanai@mdanderson.org
Advisor: Zhan Fan, M.D.
GSBS Start Date: 2007

Research Focus: Breast tumor kinase (Brk) is a nonreceptor protein tyrosine kinase that is highly expressed in breast cancers. Co-overexpression of Brk and HER2 are frequently observed in breast cancer patients. Midan's research interests focus on determining the biological link and clinical significance between Brk and HER2 and their downstream substrates with respect to breast cancer tumorigenesis and to development of resistance to HER2-targeted therapy.

Education:

  • B.S. in Biology from Lanzhou University, China, 2001
  • M.S. in Biology from Central South University, China, 2004

Lin Chen

Lin ChenEmail: lin.chen@uth.tmc.edu
Advisor: Gábor Balázsi, Ph.D.
GSBS Start Date: 2011

Research Focus: Under certain stress, cell survival could be regulated by gene expression noise and feedback regulation, which both would effect the development of drug resistance. My research focuses on stress and dose response in populations of cells with positive feedback regulation by utilizing various molecular techniques, statistical analysis and matlab programming.

Education:

  • B.S. from Huazhong Agricultural University, 2006
  • M.Sc. from Wayne State University, 2009

Lu Chen

Lu ChenEmail: lu.chen@uth.tmc.edu
Advisor: Shuxing Zhang, Ph.D.
GSBS Start Date: Fall 2009

Research Focus: Computer-aided drug design against various molecular targets, QSAR modeling and molecular dynamics simulation.

Education:

 

  • B.S. in Biological Sciences from Fudan University, Shanghai, China, 2005

Tiewei (Leo) Cheng

Tiewei (Leo) ChengEmail: tiewei.cheng@uth.tmc.edu
Advisor: David J. McConkey, Ph.D.
GSBS Start Date: Fall 2008

Research Focus: Fibroblast growth factor receptors (FGFRs) comprise a subfamily of receptor tyrosine kinases (RTKs) that are master regulators of a broad spectrum of cellular and developmental processes, including apoptosis, proliferaton, migration and angiogenesis. Leo is interested in the role of FGFR inhibitors in cancer therapy and how they apply to various in vitro and in vivo ways to elucidate efficiency and mechanisms involved in FGFR inhibitors.

Education:

  • M.D. from Wenzhou Medical College, Zhejiang, China, 2005
  • M.S. from Fudan University Medical School, Shanghai, China, 2008

Pooja Dhupkar

Email: pooja.m.dhupkar@uth.tmc.edu
Advisor: Anil K. Sood, M.D.
GSBS Start Date: Fall 2010

Research Focus: Our laboratory utilizes cutting-edge nanotechnology platforms to formulate biocompatible nanoparticles for targeted drug delivery. My research is focused on investigating novel in vivo RNA interference strategies using nanoparticles to overcome resistance to current therapeutics for ovarian cancer.

Education:

  • B.S. in Pharmaceutical Sciences from University of Mumbai, 2005
  • M.S. in Pharmacology and Toxicology from University of Sciences in Philadelphia, PA, 2008

Nathan Ihle

Nathan IhleEmail: ntihle@mdanderson.org
Advisor: Garth Powis, D.Phil.
GSBS Start Date: Fall 2010

Research Focus: The KRas oncogene is known to mediate cancer growth and survival and predicts resistance to current therapies. Nathan's research focuses on how this oncogene activates multiple signaling cascades responsible for tumor growth. Additionally, agents targeting KRas signaling are being investigated.

Education:

  • B.S. in Environmental Biology from the University of Arizona

Haiquan Lu

Haiquan LuEmail: hlu3@mdanderson.org
Advisor: Zhen Fan, M.D.
GSBS Start Date: 2008

Research Focus: Hypoxia-inducible factor 1 (HIF-1) plays a key role in regulating cancer metabolism through activating glucose transporters and glycolytic enzymes, leading to the activation of glycolysis and inhibition of oxidative phorphorylation in cancer (the Warburg Effect). Downregulation of HIF-1 is required for the antitumor role or cetuximab, an anti-EGFR monoclonal antibody. My research is focused on the metabolic role of HIF-1 in EGFR-targeted therapy in head and neck cancer.

Education:

  • B.S. in Biological Sciences from Shandong Normal University, China, 2006
  • M.S. in Cellular and Molecular Biology from Fordham University, New York, 2008

Michelle Martinez-Rivera

Michelle Martinez-RiveraEmail: mmartinez7@mdanderson.org
Advisor: Zahid H. Siddik, Ph.D.
GSBS Start Date: Fall 2010

Research Focus: Loss of antitumor response in the presence of Wild-Type p53

Education: 

 

  • B.S. in Chemistry from the University of Puerto Rico, Rio Piedras, 2010

John Morrow

John MorrowEmail: john.k.morrow@uth.tmc.edu
Advisor: Shuxing Zhang, Ph.D.
GSBS Start Date: Fall 2009

Research Focus: Rational/computational design of cancer therapeutics, which includes druggability evaluation, molecular docking and ADME-Toxicology in silico predictions. John also is interested in polypharmacology and molecular networks.

Education:

  • B.S. in Molecular Toxicology from the University of California at Berkeley, 2005

Viralkumar Patel

Viralkumar PatelEmail: viralkumar.m.patel@uth.tmc.edu
Advisor: Varsha Gandhi, Ph.D.
GSBS Start Date: Fall 2009

Research Focus: Study of transcriptional and translational modification in chronic lymphocytic leukemia cells due to their interaction with marrow stromal environment.

Education:

  • B.S. in Pharmacy from Anand University College, India
  • M.S. in Cell and Molecular Biology from Grand Valley State University, Michigan

Shubhchintan Randhawa

Shubhchintan RandhawaEmail: srandhawa@mdanderson.org
Advisor: Kapil Mehta, Ph.D.
GSBS Start Date: Summer 2010

Research Focus: The role of Transglutaminase 2 in breast cancer development.

Education:

 

  • B.Sc. (Honors) in Biotechnology from University of Hertfordshire, UK, 2008
  • M.Sc. in Cancer Cell and Molecular Biology from University of Liecester, UK, 2009

Kausar Begam Riaz Ahmed

Kausar Begam Riaz AhmedEmail: kriaz@mdanderson.org
Advisor: Peng Huang, M.D., Ph.D.
GSBS Start Date: Fall 2008

Research Focus: Malignant metastatic melanoma is the leading cause of skin cancer death in the U.S. Kausar is primarily interested in characterizing the drivers of melanoma progression and developing therapies against them. She is working to identify the mechanism of action of a naturally occurring anticancer agent, OSW-1, in melanoma. Her main focus is to identify the molecular targets of OSW-1 and use this information to further enhance the current understanding of melanoma biology.

Education:

  • B.Tech. in Industrial Biotechnology from Anna University, 2006
  • M.S. in Biotechnology from University of Utah, 2008

Nilsa Rivera-Del Valle

Nilsa Rivera-Del ValleEmail: nrivera@mdanderson.org
Advisor: Joya Chandra, Ph.D.
GSBS Start Date: 2007

Research Focus: Nilsa’s broad research interest is in the treatment of hematological malignancies. The major goal of her research is to understand the mechanism of action of combinatory therapy; especially how oxidative stress might enhance the efficacy of biologically targeted agents. Understanding how combinatory therapies work could be used for the development of more effective clinical trials.

Education:

  • B.S. in Microbiology from Inter American University of Puerto Rico, 2001
  • M.S. in Toxicology from The University of Texas Graduate School of Biomedical Sciences at Houston, 2007

Maitri Shah

Maitri ShahEmail: maitri.y.shah@uth.tmc.edu
Advisor: George A. Calin, M.D., Ph.D.
GSBS Start Date: Fall 2010

Research Focus: MicroRNAs and other non-coding RNAs play an important role in cancer initiation and progression. Maitri is interested in elucidating the role of long, non-coding RNAs in cancer initiation and identifying novel approaches to target these RNAs.

Education:

  • B.Pharm. from Mumbai University Institute of Chemical Techology, India, 2008
  • M.S. in Molecular Biology and Biotechnology from East Carolina University, N.C., 2010

Thuy Vu

Thuy VuEmail: ttvu@mdanderson.org; thuy.t.vu@uth.tmc.edu
Advisor: Francois-Xavier Claret, Ph.D.
GSBS Start Date: Fall 2009

Research Focus: The c-Jun coactivator JAB1 is a novel oncogene which has been found to aberrantly express in the progression of human breast cancer and contribute to trastuzumab resistance in Her2 positive cancer patients. Thuy's focus is on the mechanism of JAB1 gene expression and its deregulation in cancer cells to develop a new approach for targeted cancer therapy.

Education:

  • B.S. in Biotechnology from Vietnam National University at Ho Chi Minh City, 2008

Matt White

Matt WhiteEmail: mcwhite@mdanderson.org
Advisor: David J. McConkey, Ph.D.
GSBS Start Date: Fall 2007

Research Focus: Proteasome inhibitors are a potent class of chemotherapeutic agents designed to specifically target the cell's protein degradation machinery. Matt is interested in better understanding the mechanisms governing cellular response to proteasome inhibition and identifying factors that may help predict drug sensitivity or resistance in pancreatic cancer models.

Education:

  • B.S. in Molecular & Cell Biology from Texas A&M University, College Station, Texas, 2007

Qingshan (Carly) Yang

Qingshan (Carly) YangEmail: qingshan.yang@uth.tmc.edu; qyang2@mdanderson.org
Advisor: Varsha Gandhi, Ph.D.
GSBS Start Date: Fall 2009

Research Focus: Carly is investigating Pim kinase function and the therapeutic effects of its inhibitor in lymphoma. She is interested in Pim kinase driving mechanisms in hemetological cancers and identifying novel approaches to target lymphoma.

Education:

  • B.A. in Biochemistry from Ohio Weslayan University, Delaware, Ohio, 2009

Xue Zhang

Xue ZhangEmail: xue.zhang@uth.tmc.edu
Advisor: Judith A. Smith, Pharm.D.
GSBS Start Date: Fall 2009

Research Focus: Phytoestrogens become more and more popular in current clinical applications, e.g. cancer prevention and hormone replacement therapy. Xue's research focuses on the impact of phytoestrogens on estrogen-mediated cancers, specifically, estrogen-receptor interaction, cell cycle regulation, tumor growth and metastasis. Since lay press and preliminary data show quite conflictive results, this deep investigation on mechanisms of phytoestrogens action will address important clinical evidences and implications for use in cancer.

Education:

  • B.S. in Pharmaceutical Sciences from Shandong University, Jinan, Shandong Province, P.R. China
  • M.S. in Biological Science from The University of Texas at San Antonio

Program Graduates

Han, Amy

 

Links

Listed here are links to a few sites that you may find helpful. 

GSBS

Policies and Procedures

Academic Calendar

Forms

GSA

Awards

FAQs 

Other Useful Links

Note: Pages will open in a new browser window.

Texas Medical Center

City of Houston

Harris County

State of Texas

Greater Houston Convention and Visitors Bureau


© 2012 The University of Texas MD Anderson Cancer Center